文献速递甲状腺疾病

瑞典Graves甲亢患者的治疗与酰基肉碱水平变化相关

Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels.
PubMed 文献 · Thyroid · 2017-08-18

该研究在瑞典Malmö内分泌门诊对10例Graves病(GD)患者基线和治疗9、15个月时血浆80种代谢物进行 profiling,并在20例GD患者基线及3、6、9个月时验证。治疗3个月甲状腺功能恢复正常后,19种可检测酰基肉碱中9种水平改变(多重检验校正后p<0.05),表现为短链降低、中链升高、长链不变。

要点

  • Graves病治疗恢复甲状腺功能正常后,9/19种可检测酰基肉碱水平发生改变(p<0.05,多重检验校正后)。
  • 短链酰基肉碱水平降低,中链酰基肉碱升高,长链酰基肉碱无变化。
  • 上述变化可能受种族和/或饮食差异影响。

核心结论

  • Graves病及其治疗与酰基肉碱水平呈明显的酰基链长依赖性改变相关。
  • 这些变化可能受种族和/或饮食差异影响。

研究设计与样本

  • 研究在瑞典Malmö内分泌门诊开展,对10例Graves病患者基线和治疗9、15个月时血浆80种代谢物进行profiling,并随访甲状腺参数。
  • 主要发现在20例Graves病患者基线及3、6、9个月时血浆中验证。

主要发现

  • 治疗3个月甲状腺功能恢复正常,15个月随访期间甲状腺状态无进一步变化。
  • 19种可检测酰基肉碱中9种水平改变(多重检验校正后p<0.05)。
  • 短链酰基肉碱水平降低,中链酰基肉碱升高,长链酰基肉碱无变化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hyperthyroidism is associated with alterations in metabolism that are currently only partially understood. The objective of the study was to investigate changes in metabolism associated with reinstatement of euthyroidism in Swedish patients. METHODS: Eighty metabolites in plasma were profiled from 10 subjects with Graves' disease (GD) at baseline and after 9 and 15 months of treatment to reinstate euthyroidism. Thyroid parameters, thyrotropin (TSH), TSH receptor antibodies, free triiodothyronine, and free thyroxine were followed. Main findings were validated in plasma from 20 subjects with GD at baseline and at three, six, and nine months. The study was conducted at the endocrinology clinic in Malmö, Sweden. RESULTS: Euthyroidism was reinstated at three months, and thyroid status did not change further during the 15-month follow-up. This was paralleled by altered levels of 9/19 detected acylcarnitines (p < 0.05 after adjustment for multiple testing). Levels of short-chain acylcarnitines were decreased, intermediate-chain acylcarnitines elevated, and long-chain acylcarnitines unaltered. CONCLUSIONS: GD and treatment of the disease is associated with pronounced acyl chain length-dependent alterations in acylcarnitine levels. These changes may be impacted by ethnicity and or dietary differences.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Al-Majdoub M, Lantz M, Spégel P, et al. Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels. Thyroid. 2017. PMID: 28699427. doi:10.1089/thy.2017.0218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。